P3 Health Partners Inc. (PIII)
Stock analysis · NASDAQ · Healthcare · Medical - Care Facilities
P3 Health Partners Inc. (PIII) is a publicly traded company in the Healthcare sector. Latest price: $4.03. Market cap $13.20M. Trailing PE -0.12. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 6 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Valuation
| P/E (TTM) | -0.12× |
|---|---|
| P/S (TTM) | 0.01× |
| P/B | 0.19× |
| P/FCF (TTM) | -0.10× |
| EV / EBITDA | -1.48× |
| EV / Sales | 0.08× |
| Earnings Yield | -726.55% |
| Free Cash Flow Yield | -987.72% |
Fundamentals
| Enterprise Value | $122.20M |
|---|---|
| Revenue (TTM) | $1.50B |
| Net Income (TTM) | -$95.92M |
| Free Cash Flow (TTM) | -$67.44M |
| Net Debt | $109.00M |
| Working Capital | -$209.24M |
| Gross Margin | 31.65% |
| Operating Margin | -9.89% |
| Net Margin | -6.55% |
| Return on Equity | 160.54% |
| Return on Invested Capital | -51.68% |
Peers
Recent News
- P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
- 20/20 Biolabs (NASDAQ:AIDX) and P3 Health Partners (NASDAQ:PIII) Head-To-Head Review
- P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
- P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
- Contrasting P3 Health Partners (NASDAQ:PIII) & McKesson (NYSE:MCK)
Related
Browse more tickers: sitemap